Active Ingredient: BUDESONIDE
Proprietary Name: BUDESONIDE
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 9MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A205457
Product Number: 001
Approval Date: Jul 3, 2018
Applicant Holder Full Name: ACTAVIS LABORATORIES FL INC
Marketing Status:
Prescription
Patent and Exclusivity Information
